Clinical Trial

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-30.
Trial Details
NCT Number NCT06999590
Lead Sponsor Tiger Biosciences, LLC.
Collaborators: ExtremityCare, LLC., SerenaGroup, Inc.
Conditions Pressure Ulcer, Ulcer, Ulcer, Pressure, Pressure Injury
Enrollment 500 participants
Start Date 2025-05-20
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-05